Last update:

Clinical pharmacology news

Cancer cell 'degraders' target two proteins at once to defeat treatment resistance

Researchers from two Technion faculties have jointly developed a new compound and demonstrated its effectiveness against aggressive tumor cells.

Experimental drug alleviates symptoms of Huntington's disease

The hereditary disorder Huntington's disease has so far been considered incurable. Its clinical manifestations include impaired motor control and psychiatric symptoms. A new study offers promising insights. It shows that ...

Three-in-one vaccine shows promise against 'tripledemic'

Flu season is no longer just flu season. Since 2022, the health care community has faced what's known as a "tripledemic" of seasonal influenza, COVID-19 and respiratory syncytial virus (RSV). That may mean the flu shot needs ...